Better Buy: Vertex Pharmaceuticals vs. Biogen
2021 is now in the rearview mirror, and the broader market had yet another solid year. Unfortunately, not every company can say the same. Here's a pair of biotech giants that had a year to forget: Vertex Pharmaceuticals (NASDAQ: VRTX) and Biogen (NASDAQ: BIIB).
Both of these companies have challenges and opportunities. And given the beating they've endured in the trailing-12-month period, it may be worth considering their shares now, provided a rebound is in the cards.
But which of these two companies is more likely to perform well in 2022 and beyond? Let's compare these two drugmakers and decide which is the better buy today.
Source Fool.com
